Can GLP-1 and GIP Receptor Agonists Change the Trajectory of Psychiatric Disease?
The Potential of GLP-1 and GIP Receptor Agonists as Therapies for Psychiatric Disorders The Promise of Incretin Therapy for Chronic Diseases Recent developments in the field of medical research have shed light on the potential benefits of incretin therapy drugs such as GLP-1 and GIP receptor agonists. These drugs, originally acclaimed for their clinical efficacy … Read more
